Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer
Background Robust data on patient-reported outcome measures comparing treatments for clinically localized prostate cancer are lacking. We investigated the effects of active monitoring, radical prostatectomy, and radical radiotherapy with hormones on patient-reported outcomes. Methods We compared pat...
Main Authors: | Donovan, J, Hamdy, F, Lane, J, Mason, M, Metcalfe, C, Walsh, E, Blazeby, J, Peters, T, Holding, P, Bonnington, S, Lennon, T, Bradshaw, L, Cooper, D, Herbert, P, Howson, J, Jones, A, Lyons, N, Salter, E, Thompson, P, Tidball, S, Blaikie, J, Gray, C, Bollina, P, Catto, J, Doble, A, Doherty, A, Gillatt, D, Kockelbergh, R, Kynaston, H, Paul, A, Powell, P, Prescott, S, Rosario, D, Rowe, E, Davis, M, Turner, E, Martin, R, Neal, D, ProtecT Study Group |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Massachusetts Medical Society
2016
|
Similar Items
-
Mortality among nen with advanced prostate cancer excluded from the ProtecT Trial
by: Johnston, T, et al.
Published: (2016) -
10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer
by: Hamdy, F, et al.
Published: (2016) -
Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the protecT randomised controlled trial according to treatment received
by: Neal, D, et al.
Published: (2019) -
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT
by: Hamdy, FC, et al.
Published: (2020) -
A Peer Review Intervention for Monitoring and Evaluating sites (PRIME) that improved randomized controlled trial conduct and performance.
by: Lane, J, et al.
Published: (2011)